Gambro gets $3bn from DaVita for US dialysis clinics
This article was originally published in Clinica
Executive Summary
Gambro has agreed to sell its US dialysis clinics to rival DaVita, in return for $3.05bn in cash. The deal will also involve supply and R&D relationship commitments.